Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement
Journal of the American Heart Association · 04.03.2025 · 14 (5)
DOI: 10.1161/jaha.124.037296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 04.03.2025. Verfasst von Felicitas Boeckling und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cardiovascular Regeneration, Goethe University Frankfurt am Main Germany. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Tissue Inhibitor of Metalloproteinase-1, Extracellular Matrix Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cardiac fibrosis is common in patients with severe aortic stenosis and an independent predictor of death. Therefore, we examined the additional value of circulating fibrosis markers as a putative biomarker platform to identify patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) who are at a higher risk of death.
Methods
In this study, 2‐year survival analyses were conducted in 378 consecutive patients undergoing TAVR to evaluate the association between fibrosis marker and risk of adverse long‐term outcome. Implementation of fibrosis marker into TAVR risk stratification was tested by a machine‐learning algorithm.
Results
Among 20 circulating fibrosis markers involved in pathological extracellular matrix remodeling, high tissue inhibitor of metalloproteinase‐1 (TIMP‐1) levels independently predicted risk of death in univariable (hazard ratio, 5.0 [95% CI, 2.6–9.7]; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cardiovascular Regeneration, Goethe University Frankfurt am Main Germany.
- Department of Cardiology Goethe University Frankfurt, University Hospital Frankfurt Germany.
- German Centre for Cardiovascular Research, Berlin Partner Site Frankfurt Rhine-Main Frankfurt Germany.
ORCID-Profile: Silvia Mas-Peiro, David Leistner, Stefanie Dimmeler, Badder Kattih
Zitieren
APA
Boeckling, F., Rasper, T., Zanders, L., Pergola, G., Cremer, S., Mas-Peiro, S., Vasa-Nicotera, M., Leistner, D., Dimmeler, S., & Kattih, B. (2025). Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Heart Association, 14(5). https://doi.org/10.1161/jaha.124.037296
Vancouver
Boeckling F, Rasper T, Zanders L, Pergola G, Cremer S, Mas-Peiro S, et al. Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Heart Association. 2025;14(5). doi:10.1161/jaha.124.037296
BibTeX
@article{Boeckling2025,
author = {Boeckling, Felicitas and Rasper, Tina and Zanders, Lukas and Pergola, Graziella and Cremer, Sebastian and Mas-Peiro, Silvia and Vasa-Nicotera, Mariuca and Leistner, David and Dimmeler, Stefanie and Kattih, Badder},
title = {Extracellular Matrix Proteins Improve Risk Prediction in Patients Undergoing Transcatheter Aortic Valve Replacement},
journal = {Journal of the American Heart Association},
year = {2025},
volume = {14},
number = {5},
doi = {10.1161/jaha.124.037296}
}
EUVIMED